Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kikuchi's lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome.
Vassilakopoulos TP, Pangalis GA, Siakantaris MP, Levidou G, Yiakoumis X, Floudas C, Gribabis D, Bouros S, Metaxas I, Dimitriadou EM, Pantazi L, Tsoukala C, Korkolopoulou P, Andreopoulos A, Vaiopoulos G. Vassilakopoulos TP, et al. Among authors: pangalis ga. Rheumatol Int. 2010 May;30(7):925-32. doi: 10.1007/s00296-009-1077-2. Epub 2009 Aug 20. Rheumatol Int. 2010. PMID: 19693507
Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
Diamantopoulos PT, Polonyfi K, Sofotasiou M, Mantzourani M, Galanopoulos A, Spanakis N, Papadopoulou V, Kalala F, Iliakis T, Zareifi DS, Kodandreopoulou E, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Terpos E, Variami E, Kollia P, Vaiopoulos G, Pangalis G, Viniou NA. Diamantopoulos PT, et al. Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):56-60. doi: 10.1016/j.clml.2013.09.002. Epub 2013 Oct 1. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24262330
Cessation of tyrosine kinase inhibitors in patients with chronic-phase chronic myelogenous leukemia following durable complete molecular response: a single center facing the dilemma.
Iliakis T, Papadopoulou V, Diamantopoulos PT, Panayiotidis P, Zervakis K, Giannakopoulou N, Tilimidos G, Angelopoulou M, Siakantaris MP, Pangalis G, Mantzourani M, Variami E, Viniou NA. Iliakis T, et al. Anticancer Res. 2013 Aug;33(8):3509-14. Anticancer Res. 2013. PMID: 23898127
231 results